Role of the hepatocyte growth factor receptor, c-Met, in oncogenesis and potential for therapeutic inhibition

Cooper, 1984, Molecular cloning of a new transforming gene from a chemically transformed human cell line, Nature, 311, 29, 10.1038/311029a0 Park, 1986, Mechanism of met oncogene activation, Cell, 45, 895, 10.1016/0092-8674(86)90564-7 Jeffers, 1996, Enhanced tumorigenicity and invasion-metastasis by hepatocyte growth factor/scatter factor–met signalling in human cells concomitant with induction of the urokinase proteolysis network, Mol. Cell Biol., 16, 1115, 10.1128/MCB.16.3.1115 Jeffers, 1997, Activating mutations for the met tyrosine kinase receptor in human cancer, Proc. Natl. Acad. Sci. USA, 94, 11445, 10.1073/pnas.94.21.11445 Liu, 1998, The human hepatocyte growth factor receptor gene: complete structural organization and promoter characterization, Gene, 215, 159, 10.1016/S0378-1119(98)00264-9 Furge, 2000, Met receptor tyrosine kinase: enhanced signaling through adapter proteins, Oncogene, 19, 5582, 10.1038/sj.onc.1203859 Wahl, 1999, Chicken macrophage stimulating protein is a ligand of the receptor protein–tyrosine kinase Sea, J. Biol. Chem., 274, 26361, 10.1074/jbc.274.37.26361 Artigiani, 1999, Plexins, semaphorins, and scatter factor receptors: a common root for cell guidance signals?, IUBMB Life, 48, 477, 10.1080/713803563 Tamagnone, 2000, Signalling by semaphorin receptors: cell guidance and beyond, Trends Cell Biol., 10, 377, 10.1016/S0962-8924(00)01816-X Comoglio, 1999, Plasminogen-related growth factor and semaphorin receptors: a gene superfamily controlling invasive growth, Exp. Cell Res., 253, 88, 10.1006/excr.1999.4684 Lu, 2001, Homeostatic regulation of the immune system by receptor tyrosine kinases of the Tyro 3 family, Science, 293, 306, 10.1126/science.1061663 Comoglio, 1993, Structure, biosynthesis and biochemical properties of the HGF receptor in normal and malignant cells, Exs., 65, 131 Comoglio, 1996, The HGF receptor family: unconventional signal transducers for invasive cell growth, Genes Cells, 1, 347, 10.1046/j.1365-2443.1996.37037.x Seki, 1991, Organization of the human hepatocyte growth factor-encoding gene, Gene, 102, 213, 10.1016/0378-1119(91)90080-U Mars, 1993, Activation of hepatocyte growth factor by the plasminogen activators uPA and tPA, Am. J. Pathol., 143, 949 Longati, 2001, Receptor tyrosine kinases as therapeutic targets: the model of the MET oncogene, Curr. Drug Targets, 2, 41, 10.2174/1389450013348920 Jeffers, 1998, Signaling requirements for oncogenic forms of the Met tyrosine kinase receptor, Oncogene, 17, 2691, 10.1038/sj.onc.1202209 Jeffers, 1998, The mutationally activated Met receptor mediates motility and metastasis, Proc. Natl. Acad. Sci. USA, 95, 14417, 10.1073/pnas.95.24.14417 Jeffers, 1996, Hepatocyte growth factor/scatter factor–Met signaling in tumorigenicity and invasion/metastasis, J. Mol. Med., 74, 505, 10.1007/BF00204976 Bieche, 1999, Infrequent mutations of the MET gene in sporadic breast tumours (letter), Int. J. Cancer, 82, 908, 10.1002/(SICI)1097-0215(19990909)82:6<908::AID-IJC22>3.0.CO;2-N Camp, 1999, Met expression is associated with poor outcome in patients with axillary lymph node negative breast carcinoma, Cancer, 86, 2259, 10.1002/(SICI)1097-0142(19991201)86:11<2259::AID-CNCR13>3.0.CO;2-2 Nakopoulou, 2000, c-met tyrosine kinase receptor expression is associated with abnormal beta-catenin expression and favourable prognostic factors in invasive breast carcinoma, Histopathology, 36, 313, 10.1046/j.1365-2559.2000.00847.x Liu, 1992, Over-expression of c-met proto-oncogene but not epidermal growth factor receptor or c-erbB-2 in primary human colorectal carcinomas, Oncogene., 7, 181 Umeki, 1999, Clinical significance of c-met oncogene alterations in human colorectal cancer, Oncology, 56, 314, 10.1159/000011985 Kuniyasu, 1992, Frequent amplification of the c-met gene in scirrhous type stomach cancer, Biochem. Biophys. Res. Commun., 189, 227, 10.1016/0006-291X(92)91548-5 Kuniyasu, 1993, Aberrant expression of c-met mRNA in human gastric carcinomas, Int. J. Cancer, 55, 72, 10.1002/ijc.2910550114 Park, 2000, Absence of mutations in the kinase domain of the Met gene and frequent expression of Met and HGF/SF protein in primary gastric carcinomas, Apmis, 108, 195, 10.1034/j.1600-0463.2000.d01-44.x Lee, 2000, A novel germ line juxtamembrane Met mutation in human gastric cancer, Oncogene, 19, 4947, 10.1038/sj.onc.1203874 Moriyama, 1995, Concomitant expression of hepatocyte growth factor (HGF), HGF activator and c-met genes in human glioma cells in vitro, FEBS Lett., 372, 78, 10.1016/0014-5793(95)00949-A Moon, 2000, Missense mutation of the MET gene detected in human glioma, Mod. Pathol., 13, 973, 10.1038/modpathol.3880177 Di Renzo, 2000, Somatic mutations of the met oncogene are selected during metastatic spread of human HNSC carcinomas, Oncogene, 19, 1547, 10.1038/sj.onc.1203455 Suzuki, 1994, Expression of the c-met proto-oncogene in human hepatocellular carcinoma, Hepatology, 20, 1231, 10.1002/hep.1840200520 Park, 1999, Somatic mutations in the kinase domain of the Met/hepatocyte growth factor receptor gene in childhood hepatocellular carcinomas, Cancer Res., 59, 307 Schmidt, 1997, Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas, Nat Genet, 16, 68, 10.1038/ng0597-68 Schmidt, 1998, Two North American families with hereditary papillary renal carcinoma and identical novel mutations in the MET proto-oncogene, Cancer Res., 58, 1719 Fischer, 1998, Duplication and over-expression of the mutant allele of the MET proto-oncogene in multiple hereditary papillary renal cell tumours, Oncogene., 17, 733, 10.1038/sj.onc.1201983 Zhuang, 1998, Trisomy 7-harbouring non-random duplication of the mutant MET allele in hereditary papillary renal carcinomas, Nat Genet, 20, 66, 10.1038/1727 Olivero, 1999, Novel mutation in the ATP-binding site of the MET oncogene tyrosine kinase in a HPRCC family, Int. J. Cancer, 82, 640, 10.1002/(SICI)1097-0215(19990827)82:5<640::AID-IJC4>3.0.CO;2-6 Schmidt, 1999, Novel mutations of the MET proto-oncogene in papillary renal carcinomas, Oncogene, 18, 2343, 10.1038/sj.onc.1202547 Jucker, 1994, The Met/hepatocyte growth factor receptor (HGFR) gene is over-expressed in some cases of human leukemia and lymphoma, Leuk. Res., 18, 7, 10.1016/0145-2126(94)90003-5 Rong, 1995, Met proto-oncogene product is over-expressed in tumors of p53-deficient mice and tumors of Li-Fraumeni patients, Cancer Res., 55, 1963 Tolnay, 1998, Hepatocyte growth factor/scatter factor and its receptor c-Met are over-expressed and associated with an increased microvessel density in malignant pleural mesothelioma, J. Cancer Res. Clin. Oncol., 124, 291, 10.1007/s004320050171 Klominek, 1998, Hepatocyte growth factor/scatter factor stimulates chemotaxis and growth of malignant mesothelioma cells through c-met receptor, Int. J. Cancer, 76, 240, 10.1002/(SICI)1097-0215(19980413)76:2<240::AID-IJC12>3.0.CO;2-G Thirkettle, 2000, Immunoreactivity for cadherins, HGF/SF, met, and erbB-2 in pleural malignant mesotheliomas, Histopathology, 36, 522, 10.1046/j.1365-2559.2000.00888.x Natali, 1993, Expression of the c-Met/HGF receptor in human melanocytic neoplasms: demonstration of the relationship to malignant melanoma tumour progression, Br. J. Cancer, 68, 746, 10.1038/bjc.1993.422 Hjertner, 1999, Hepatocyte growth factor (HGF) induces interleukin-11 secretion from osteoblasts: a possible role for HGF in myeloma-associated osteolytic bone disease, Blood, 94, 3883, 10.1182/blood.V94.11.3883 Liu, 1993, In vitro and in vivo expressions of transforming growth factor-alpha and tyrosine kinase receptors in human non-small-cell lung carcinomas, Am. J. Pathol., 142, 1155 Olivero, 1996, Over-expression and activation of hepatocyte growth factor/scatter factor in human non-small-cell lung carcinomas, Br J. Cancer, 74, 1862, 10.1038/bjc.1996.646 Ichimura, 1996, Expression of c-met/HGF receptor in human non-small cell lung carcinomas in vitro and in vivo and its prognostic significance, Jpn. J. Cancer Res., 87, 1063, 10.1111/j.1349-7006.1996.tb03111.x Takanami, 1996, Hepatocyte growth factor and c-Met/hepatocyte growth factor receptor in pulmonary adenocarcinomas: an evaluation of their expression as prognostic markers, Oncology, 53, 392, 10.1159/000227594 Siegfried, 1998, The clinical significance of hepatocyte growth factor for non-small cell lung cancer, Ann Thorac. Surg., 66, 1915, 10.1016/S0003-4975(98)01165-5 Tokunou, 2001, c-MET expression in myofibroblasts: role in autocrine activation and prognostic significance in lung adenocarcinoma, Am J. Pathol., 158, 1451, 10.1016/S0002-9440(10)64096-5 Ferracini, 1995, The Met/HGF receptor is over-expressed in human osteosarcomas and is activated by either a paracrine or an autocrine circuit, Oncogene, 10, 739 Di Renzo, 1994, Over-expression of the Met/HGF receptor in ovarian cancer, Int. J. Cancer, 58, 658, 10.1002/ijc.2910580507 Sowter, 1999, Hepatocyte growth factor (HGF) in ovarian epithelial tumour fluids stimulates the migration of ovarian carcinoma cells, Int. J. Cancer, 83, 476, 10.1002/(SICI)1097-0215(19991112)83:4<476::AID-IJC7>3.0.CO;2-V Ebert, 1994, Co-expression of the c-met proto-oncogene and hepatocyte growth factor in human pancreatic cancer, Cancer Res., 54, 5775 Pisters, 1995, c-met proto-oncogene expression in benign and malignant human prostate tissues, J. Urol., 154, 293, 10.1016/S0022-5347(01)67297-5 Humphrey, 1995, Hepatocyte growth factor and its receptor (c-MET) in prostatic carcinoma, Am J. Pathol., 147, 386 Rygaard, 1993, Expression of the proto-oncogenes c-met and c-kit and their ligands, hepatocyte growth factor/scatter factor and stem cell factor, in SCLC cell lines and xenografts, Br J. Cancer, 67, 37, 10.1038/bjc.1993.7 Oda, 2000, Expression of hepatocyte growth factor (HGF)/scatter factor and its receptor c-MET correlates with poor prognosis in synovial sarcoma, Hum. Pathol., 31, 185, 10.1016/S0046-8177(00)80218-X Di Renzo, 1995, Over-expression of the c-MET/HGF receptor in human thyroid carcinomas derived from the follicular epithelium, J. Endocrinol. Invest, 18, 134, 10.1007/BF03349722 Gohji, 2000, Independent prognostic value of serum hepatocyte growth factor in bladder cancer, J. Clin. Oncol., 18, 2963, 10.1200/JCO.2000.18.16.2963 Niemann, 1998, Reconstitution of mammary gland development in vitro: requirement of c-met and c-erbB2 signaling for branching and alveolar morphogenesis, J. Cell Biol., 143, 533, 10.1083/jcb.143.2.533 Bladt, 1995, Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud (see comments), Nature, 376, 768, 10.1038/376768a0 Stella, 1999, HGF: a multifunctional growth factor controlling cell scattering, Int. J. Biochem. Cell Biol., 31, 1357, 10.1016/S1357-2725(99)00089-8 van der Voort, 2000, The hepatocyte growth factor/Met pathway in development, tumorigenesis, and B-cell differentiation, Adv. Cancer Res., 79, 39, 10.1016/S0065-230X(00)79002-6 Warburton, 2000, The molecular basis of lung morphogenesis, Mech. Dev., 92, 55, 10.1016/S0925-4773(99)00325-1 Boccaccio, 1998, Induction of epithelial tubules by growth factor HGF depends on the STAT pathway, Nature, 391, 285, 10.1038/34657 Hammond, 2001, Down-regulation of MET, the receptor for hepatocyte growth factor, Oncogene, 20, 2761, 10.1038/sj.onc.1204475 Jeffers, 1997, Degradation of the Met tyrosine kinase receptor by the ubiquitin–proteasome pathway, Mol. Cell Biol., 17, 799, 10.1128/MCB.17.2.799 Folkman, 2001, Angiogenesis research: guidelines for translation to clinical application, Thromb. Haemost., 86, 23, 10.1055/s-0037-1616197 Rosen, 1997, HGF/SF in angiogenesis, Ciba Found Symp., 212, 215 Dong, 2001, Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma, Cancer Res., 61, 5911 Arakaki, 1999, Involvement of oxidative stress in tumor cytotoxic activity of hepatocyte growth factor/scatter factor, J. Biol. Chem., 274, 13541, 10.1074/jbc.274.19.13541 Mitchison, 1996, Actin-based cell motility and cell locomotion, Cell, 84, 371, 10.1016/S0092-8674(00)81281-7 Weisberg, 1997, Role of focal adhesion proteins in signal transduction and oncogenesis, Crit. Rev. Oncog., 8, 343, 10.1615/CritRevOncog.v8.i4.40 Kermorgant, 2001, Hepatocyte growth factor induces colonic cancer cell invasiveness via enhanced motility and protease overproduction. Evidence for PI3 kinase and PKC involvement, Carcinogenesis, 22, 1035, 10.1093/carcin/22.7.1035 Curran, 2000, Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis, Eur. J. Cancer, 36, 1621, 10.1016/S0959-8049(00)00156-8 Hotary, 2000, Regulation of cell invasion and morphogenesis in a three-dimensional type I collagen matrix by membrane-type matrix metalloproteinases 1, 2, and 3, J. Cell Biol., 149, 1309, 10.1083/jcb.149.6.1309 Sattler, 1999, Hematopoietic growth factors signal through the formation of reactive oxygen species, Blood, 93, 2928, 10.1182/blood.V93.9.2928.409k25_2928_2935 Sattler, 1998, Role of the adapter protein CRKL in signal transduction of normal hematopoietic and BCR/ABL-transformed cells, Leukemia, 12, 637, 10.1038/sj.leu.2401010 Sattler, 2000, Role of the cytoskeletal protein paxillin in oncogenesis, Crit. Rev Oncog., 11, 63, 10.1615/CritRevOncog.v11.i1.30 Hynes, 1992, Integrins: versatility, modulation, and signaling in cell adhesion, Cell, 69, 11, 10.1016/0092-8674(92)90115-S Trusolino, 1998, Growth factor-dependent activation of alphavbeta3 integrin in normal epithelial cells: implications for tumor invasion, J. Cell Biol., 142, 1145, 10.1083/jcb.142.4.1145 Lai, 2000, Involvement of focal adhesion kinase in hepatocyte growth factor-induced scatter of Madin–Darby canine kidney cells, J. Biol. Chem., 275, 7474, 10.1074/jbc.275.11.7474 Matsumoto, 1995, Growth factor regulation of integrin-mediated cell motility, Cancer Metastasis Rev., 14, 205, 10.1007/BF00690292 Parr, 2001, The HGF/SF-induced phosphorylation of paxillin, matrix adhesion, and invasion of prostate cancer cells were suppressed by NK4, an HGF/SF variant, Biochem. Biophys. Res. Commun., 285, 1330, 10.1006/bbrc.2001.5307 Jiang, 1999, Antagonistic effect of NK4, a novel hepatocyte growth factor variant, on in vitro angiogenesis of human vascular endothelial cells, Clin. Cancer Res., 5, 3695 Schaller, 1997, Differential signaling by the focal adhesion kinase and cell adhesion kinase beta, J. Biol. Chem., 272, 25319, 10.1074/jbc.272.40.25319 Shen, 1999, Focal adhesion targeting: the critical determinant of FAK regulation and substrate phosphorylation, Mol. Biol. Cell, 10, 2507, 10.1091/mbc.10.8.2507 Matsumoto, 1994, Hepatocyte growth factor/scatter factor induces tyrosine phosphorylation of focal adhesion kinase (p125FAK) and promotes migration and invasion by oral squamous cell carcinoma cells, J. Biol. Chem., 269, 31807, 10.1016/S0021-9258(18)31767-8 Nobes, 1999, Rho GTPases control polarity, protrusion, and adhesion during cell movement, J. Cell Biol., 144, 1235, 10.1083/jcb.144.6.1235 Kodama, 2000, Involvement of an SHP-2-Rho small G protein pathway in hepatocyte growth factor/scatter factor-induced cell scattering (in process citation), Mol. Biol. Cell, 11, 2565, 10.1091/mbc.11.8.2565 Royal, 2000, Activation of cdc42 rac, PAK, and rho-kinase in response to hepatocyte growth factor differentially regulates epithelial cell colony spreading and dissociation, Mol. Biol. Cell, 11, 1709, 10.1091/mbc.11.5.1709 Uemura, 1997, The BCR/ABL oncogene alters interaction of the adapter proteins CRKL and CRK with cellular proteins, Leukemia, 11, 376, 10.1038/sj.leu.2400590 Uemura, 1999, Involvement of the adapter protein CRKL in integrin-mediated adhesion, Oncogene, 18, 3343, 10.1038/sj.onc.1202689 Sakkab, 2000, Signaling of hepatocyte growth factor/scatter factor (HGF) to the small GTPase Rap1 via the large docking protein Gab1 and the adapter protein CRKL, J. Biol. Chem., 275, 10772, 10.1074/jbc.275.15.10772 Gotoh, 1995, Identification of Rap1 as a target for the Crk SH3 domain-binding guanine nucleotide-releasing factor C3G, Mol. Cell Biol., 15, 6746, 10.1128/MCB.15.12.6746 Ridley, 1995, Regulation of scatter factor/hepatocyte growth factor responses by Ras, Rac, and Rho in MDCK cells, Mol. Cell Biol., 15, 1110, 10.1128/MCB.15.2.1110 Garcia-Guzman, 1999, Met-induced JNK activation is mediated by the adapter protein Crk and correlates with the Gab1–Crk signaling complex formation, Oncogene, 18, 7775, 10.1038/sj.onc.1203198 Cantrell, 2001, Phosphoinositide 3-kinase signalling pathways, J. Cell Sci., 114, 1439, 10.1242/jcs.114.8.1439 Bowers, 2000, Scatter factor/hepatocyte growth factor protects against cytotoxic death in human glioblastoma via phosphatidylinositol 3-kinase- and AKT-dependent pathways, Cancer Res., 60, 4277 Nakanishi, 1999, Hepatocyte growth factor promotes migration of human hepatocellular carcinoma via phosphatidylinositol 3-kinase, Clin. Exp. Metastasis, 17, 507, 10.1023/A:1006685218766 Davies, 2000, Cell–cell adhesion molecules and signaling intermediates and their role in the invasive potential of prostate cancer cells, J. Urol., 163, 985, 10.1016/S0022-5347(05)67869-X Nabeshima, 1998, Hepatocyte growth factor/scatter factor induces not only scattering but also cohort migration of human colorectal-adenocarcinoma cells, Int. J. Cancer, 78, 750, 10.1002/(SICI)1097-0215(19981209)78:6<750::AID-IJC13>3.0.CO;2-# Davies, 2001, HGF/SF modifies the interaction between its receptor c-Met, and the E-cadherin/catenin complex in prostate cancer cells, Int. J. Mol. Med., 7, 385 Joensuu, 2001, Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor, New Engl. J. Med., 344, 1052, 10.1056/NEJM200104053441404 Lynch, 2000, Lung cancer highlights, Oncologist, 5, 274, 10.1634/theoncologist.5-6-531-b Webb, 2000, The geldanamycins are potent inhibitors of the hepatocyte growth factor/scatter factor met–urokinase plasminogen activator plasmin proteolytic network, Cancer Res., 60, 342 Neckers, 1999, Geldanamycin as a potential anti-cancer agent: its molecular target and biochemical activity, Invest New Drugs, 17, 361, 10.1023/A:1006382320697 Otsuka, 2000, Disassociation of met-mediated biological responses in vivo: the natural hepatocyte growth factor/scatter factor splice variant NK2 antagonizes growth but facilitates metastasis, Mol. Cell Biol., 20, 2055, 10.1128/MCB.20.6.2055-2065.2000 Parr, 2000, Nk4, a new HGF/SF variant, is an antagonist to the influence of HGF/SF on the motility and invasion of colon cancer cells, Int. J. Cancer, 85, 563, 10.1002/(SICI)1097-0215(20000215)85:4<563::AID-IJC19>3.0.CO;2-D Mark, 1992, Expression and characterization of hepatocyte growth factor receptor–IgG fusion proteins: effects of mutations in the potential proteolytic cleavage site on processing and ligand binding, J. Biol. Chem., 267, 26166, 10.1016/S0021-9258(18)35731-4 Michieli, 1999, Mutant Met-mediated transformation is ligand-dependent and can be inhibited by HGF antagonists, Oncogene, 18, 5221, 10.1038/sj.onc.1202899 Bardelli, 1999, A peptide representing the carboxyl-terminal tail of the met receptor inhibits kinase activity and invasive growth, J. Biol. Chem., 274, 29274, 10.1074/jbc.274.41.29274 Atabey, 2001, Potent blockade of hepatocyte growth factor-stimulated cell motility, matrix invasion and branching morphogenesis by antagonists of Grb2 Src homology 2 domain interactions, J. Biol. Chem., 276, 14308, 10.1074/jbc.M010202200 Sachs, 2000, Essential role of Gab1 for signaling by the c-Met receptor in vivo, J. Cell Biol., 150, 1375, 10.1083/jcb.150.6.1375 Gual, 2000, Sustained recruitment of phospholipase C-gamma to Gab1 is required for HGF-induced branching tubulogenesis, Oncogene, 19, 1509, 10.1038/sj.onc.1203514 Gual, 2001, Gab1 phosphorylation: a novel mechanism for negative regulation of HGF receptor signaling, Oncogene, 20, 156, 10.1038/sj.onc.1204047 Rahimi, 1998, c-Src kinase activity is required for hepatocyte growth factor-induced motility and anchorage-independent growth of mammary carcinoma cells, J. Biol. Chem., 273, 33714, 10.1074/jbc.273.50.33714 Nakaigawa, 2000, Tumorigenesis mediated by MET mutant M1268T is inhibited by dominant-negative Src, Oncogene, 19, 2996, 10.1038/sj.onc.1203628 Koochekpour, 1999, The von Hippel–Lindau tumor suppressor gene inhibits hepatocyte growth factor/scatter factor-induced invasion and branching morphogenesis in renal carcinoma cells, Mol. Cell Biol., 19, 5902, 10.1128/MCB.19.9.5902 Derman, 1995, HGF-mediated chemotaxis and tubulogenesis require activation of the phosphatidylinositol 3-kinase, Am J. Physiol., 268, F1211 Derman, 1996, An 11-amino acid sequence from c-met initiates epithelial chemotaxis via phosphatidylinositol 3kinase and phospholipase C, J. Biol. Chem., 271, 4251, 10.1074/jbc.271.8.4251 Graziani, 1993, Hepatocyte growth factor/scatter factor stimulates the Ras–guanine nucleotide exchanger, J. Biol. Chem., 268, 9165, 10.1016/S0021-9258(18)98327-4 Takaishi, 1994, Involvement of Rho p21 small GTP-binding protein and its regulator in the HGF-induced cell motility, Oncogene, 9, 273